4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells NFT2VlFHfW6ldHnvckBie3OjeR?= NV36dlZSSWexbnnzeIlkKGGldHn2bZR6KHejczDk[ZRmem2rbnXkJIlvKEORU{GgZ4VtdHNidILhcpNn\WO2ZXSge4l1cCCJQVygOE1RWEGUIHfhcY1iKHKnY3XweI9zNCCHQ{WwQVAvODJzIN88US=> MWmxNlYyPzl{NB?=
CV-1 cells NYWyeGN7TnWwY4Tpc44h[XO|YYm= NEOzcHNO[XirbXHsJJJmeG:{dHXyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJGdidDRiY3jpcYVzcWNiaX6geJJidnOrZX70cJkhfHKjboPm[YN1\WRiQ2[tNUBk\WyuczDifUBnfW6ldHnvcoFtKGG|c3H5MEBGSzVyPUCuNFQ{KM7:TR?= NGPLSlMyOTd{MEi1OC=>
COS-1 cells MlyxSpVv[3Srb36gZZN{[Xl? M4\nbWlvKH[rdILvJJRz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDw[ZJwgGm|b33lJJBzd2yrZnXyZZRweiCjY4TpeoF1\WRicnXj[ZB1d3JiZ3HtcYEhdWWjc4Xy[YQhcW5iUGDBVk1ISUx2IHPobY1memmlIFPPV{0yKGOnbHzzMEBGSzVyPUCuNFIh|ryP MUGxNlg4OzVzNx?=
CV-1 cells MmGySpVv[3Srb36gZZN{[Xl? MYfBZ5RqfmG2aX;uJI9nKHCncn;4bZNwdWVicILvcIln\XKjdH;yJIFkfGm4YYTl[EBz\WOncITvdkBo[W2vYTDt[YF{fXKnZDDifUBqdmS3Y4Tpc44hd2ZiNUClJI9nKG2jeHnteY0h[WytYXzpcoUheGixc4DoZZRie2ViYXP0bZZqfHluIITyZY5{\mWldHnvckBie3OjeTDpckBEXi1zIHPlcIx{NCCHQ{WwQVAvODh7MUOg{txO NYXENVhwQTh|Nk[yNC=>
CV-1 cells NUHEUnUyTnWwY4Tpc44h[XO|YYm= NYTXTWI5UW5idnn0do8hfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44hd2ZiUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJEhRWEGUKTDlfJBz\XO|ZXSgbY4hS1ZvMTDj[YxteyxiRVO1NF0xNjB4IN88US=> NWj3TWNpQDV5NkmwOy=>
COS-1 cells NUfvNIZ6TnWwY4Tpc44h[XO|YYm= MXPJckB3cXS{bzDh[49vcXO2IHHjeIl3cXS7IITld5Rm\CCob4KgeJJidnOjY4TpeoF1cW:wIHnuJIh2dWGwIGDQRXIh\2GvbXGtS4FtPCClaHnt[ZJq[yCFT2OtNUBk\WyuczygSWM2OD1yLkCyJO69VQ>? MYmxNlczQTZ4OB?=
CV-1 cells MXLGeY5kfGmxbjDhd5NigQ>? M1juTWlvKH[rdILvJIV3[Wy3YYTpc44h[WejaX7zeEBTYFJvYXzwbIEwWFCDUj3nZY1u[SCrbjDDWk0yKGOnbHzzJIJ6KGOxdILhcpNn\WO2aX;uJIF{e2G7IIfhd{Bl\XSncn3pcoVlNCCHQ{WwQVAvOzJ3IN88US=> MYexNlk2PDB4MR?=
HepG2 cells NXvYZnJtTnWwY4Tpc44h[XO|YYm= NHPzOnJG\m[nY4TpeoUh[2:wY3XueJJifGmxbjDh[4FqdnO2IHj1cYFvKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gTIVxTzJiY3XscJMtKEWFNUC9NE4xOzlizszN M2jrfVE3OTB5MUWw
Huh7 cells Ml\6SpVv[3Srb36gZZN{[Xl? MVHGeY5kfGmxbnHsJIFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> NEfwdZAyPjN4Nk[wNS=>
Huh7 cells MoLSSpVv[3Srb36gZZN{[Xl? NGfoPXlG\m[nY4Sgc44hWFCDUjDnZY1u[SC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkhcW5iSIXoO{Bk\WyuczygSWM2OD1yLkKyJO69VQ>? MWKxOlQ2OTB6Nx?=
U2OS cells M3fLbGZ2dmO2aX;uJIF{e2G7 NGDSbGxG\m[nY4Sgc44hWFCDUnfhcY1iKHS{YX7zZYN1cX[jdHnvckBi[3Srdnn0fUBqdiCXMl;TJINmdGy|LDDFR|UxRTBwMEOg{txO MYWxOlMxODl2NB?=
CV1 cells NFfnU5NHfW6ldHnvckBie3OjeR?= MmS5WJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNuIFXDOVA:OC5yN{[g{txO NIX3OI0yPjh{MUe2PS=>
human keratinocytes M1;D[3Bzd2yrZnXyZZRqd25iYYPzZZk> MkDNRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCtZYLheIlvd2O7dHXzMEBGSzVyPUig{txO NVfDS4x1OTZ6MkG3Olk>
HT29 cell MkHHVJJwdGmoZYLheIlwdiCjc4PhfS=> MVPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWMkmgZ4VtdCCuaX7lMEBGSzVyPUS1JO69VQ>? NELaTFkyPjh{MUe2PS=>
NIH3T3 cells MV3GeY5kfGmxbjDhd5NigQ>? Mn3WRYN1cX[rdImgZZQhcHWvYX6gVHBCWiCpYX3tZUB1emGwc3\lZ5Rm\CCrbjDOTWg{XDNiY3XscJMh[nlibIXjbYZmemG|ZTDhZ5Rqfmm2eTDhd5NigSxiRVO1NF0xNjN{IN88US=> MYOxOlg2PDB6NR?=
CV1 cells MW\GeY5kfGmxbjDhd5NigQ>? Ml7ZWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIGDQRXJo[W2vYTDpckBEXjFiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuN|A5KM7:TR?= M2X6TlE3QTdyM{mx
Huh7 cells NUjLPJA5TnWwY4Tpc44h[XO|YYm= M1jQVGFkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> Mn[yNVcxOzRzNEm=
HepG2 cells MXvGeY5kfGmxbjDhd5NigQ>? M2PBXmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWiCpYX3tZUBqdiCjIFjldGczKGOnbHzzJIJ6KFCSQWKtS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6xOVgh|ryP NUfpS4VJOTZ7N{OzOVg>
HepG2 cells MYjGeY5kfGmxbjDhd5NigQ>? NXvZfXJLSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUIHfhcY1iKGmwIFjldGczKGOnbHzzJIJ6KFCSQWKtS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6xOVjPxE1? NInNdZYyPjl5OUO0NS=>
CV1 cells NEPJfmZHfW6ldHnvckBie3OjeR?= M4rMbWFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNuIFXDOVA:OC5|MEig{txO NIW4fWcyPzByNUO5OC=>
HEK293 cells M4DEcmZ2dmO2aX;uJIF{e2G7 NWLyTmZQSWO2aY\peJkh[XRiaIXtZY4h[WSrcH;z[UB1cXO|dXWgVHBCWiCpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KFCSQWKtS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6zNUDPxE1? M2\DeFE4OzR|M{ex
rat L6 cells M2XiUmZ2dmO2aX;uJIF{e2G7 M17WRWVn\mWldDDvckBn[XS2eTDhZ4llKG:6aXTheIlwdiCrbjDyZZQhVDZiY3XscJMtKEWFNUC9OUDPxE1? Mle5NVc{PDN|N{G=
HepG2 cells M{\CeGZ2dmO2aX;uJIF{e2G7 NH;rR2tC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBqdiCKZYDHNkBk\WyuczDifUBRWEGULVfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMEiyJO69VQ>? NXLa[5dpOTdzNUewNVk>
CV1 cells NUTE[lBNTnWwY4Tpc44h[XO|YYm= MYPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJidHCqYTDpckBEXjFiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XliYX\0[ZIhOjRiaILzMEBGSzVyPUOuOFYh|ryP NGTuT4kyPzVyN{KyOS=>
CV1 cells NVT6fnJyTnWwY4Tpc44h[XO|YYm= M4exV2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIlvKEOYMTDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTDh[pRmeiB{NDDodpMtKEWFNUC9NE4xOyEQvF2= M3jnZVE4PTB5MkK1
CV1 cells MkC5SpVv[3Srb36gZZN{[Xl? NFTTd3RC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iQ2[xJINmdGy|IHL5JJJm[2WydH;yJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNyODFOwG0> M{S0NFE5ODJ7MUe4
CV1 cells NFXEVnJHfW6ldHnvckBie3OjeR?= MkPNRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|IHL5JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNyODFOwG0> NHrsSWQyPzF{OUeyOS=>
HEK293 cells MVrGeY5kfGmxbjDhd5NigQ>? M3P4bWFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yM{Wg{txO MnHtNVczQTJ4ME[=
NIH3T3 cells NVHwXXpvTnWwY4Tpc44h[XO|YYm= MoXIRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKE6LSEPUN{Bk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlMzKM7:TR?= NUnqSnVzOTd4MkS3O|c>
HEK293 cells MnHkSpVv[3Srb36gZZN{[Xl? NXH2PJdZSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG5JO69VQ>? NHjKcJYyQDB{OUG3Oi=>
HEK293 cells NH7VTphHfW6ldHnvckBie3OjeR?= NUf0e2lRSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDhVFIh\2WwZTDpcoR2[3Srb36sJGVEPTB;MD6xNkDPxE1? MnnlNVgxOjlzN{[=
HEK293 cells MYrGeY5kfGmxbjDhd5NigQ>? NW[xdIF6SWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiaX6gTGVMOjl|IHPlcIx{KGK7IFfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMES1JO69VQ>? Mm\NNVgzQTF4NEW=
HepG2 cells NIXYNnJHfW6ldHnvckBie3OjeR?= NU\UUWF3SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbESgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEO5JO69VQ>? M12zR|E5QDN3N{G5
RAW264.7 cells NUDW[GZDTnWwY4Tpc44h[XO|YYm= NI\u[2FUfXCycnXzd4lwdiCxZjDMVHMwUU[QLXfhcY1iNXO2aX31cIF1\WRiTl:gdJJw\HWldHnvckBqdiCvb4Xz[UBTSVd{NkSuO{Bk\WyuczygSWM2OD1zNz61JO69VQ>? MXSxPFgxQTN{NR?=
BL21 cells M37sZ2Z2dmO2aX;uJIF{e2G7 MkfKSIl{eGyjY3Xt[Y51KG:oIILh[IlwKGyjYnXs[YQhOiiVKT2oNk1j\W68b4nsMZBp\W67bHHtbY5wMS1|LYu0MXsyNDFvZHn0dol1cW9vMj2oOU1u\XSqeXytNk1xcGWweXytc5higm:uLUStfYwqNWW2aH;4fX0ueGinbonsgU1xem:yaX;ubYMh[WOrZDDmdo9uKEeVVD3meZNm\CCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFXzZ4hmemmlaHnhJINwdGliQlyyNUBk\WyuczDifUB{[2mwdHnscIF1cW:wIIDyc5hqdWm2eTDhd5NigSxiRVO1NF0xNjR3IN88US=> NFrxOYkyQTN2OUG3Oi=>
BHK21 cells M4X4SWZ2dmO2aX;uJIF{e2G7 MoCxRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEKKS{KxJINmdGy|IHHzd4V{e2WmIHHzJHNGSVBiYXP0bZZqfHliYomgcJVkcW[ncnHz[UBz\XCxcoTldkB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC52NTFOwG0> M{\3VlE6OzR7MUe2
HepG2/C3A cells NXjUSHF2TnWwY4Tpc44h[XO|YYm= MkjuRYN1cX[jdHnvckBw\iCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwLX3l[IlifGWmIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCKZYDHNk9EO0FiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVzCSEBjgSClb4TyZY5{\mWldHnvckBie3OjeTygSWM2OD1yLkCwN|gh|ryP MXixO|QxOzZ6OB?=
HepG2 cells NHP6T4xHfW6ldHnvckBie3OjeR?= MXnB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKHKnY3XweI9zKHS{YX7zZYN1cX[jdHnvckBjgSC{ZYDvdpRmeiCpZX7lJIF{e2G7IILlcIF1cX[nIITvJINwdnS{b3ysJGVEPTB;MD6wOUDPxE1? Mn\PNVg3OjV3NUm=
COS1 cells M{HqWmZ2dmO2aX;uJIF{e2G7 Mn7aRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDy[YNwdWKrbnHueEBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFPPV|Eh[2WubIOgZ48u\XiycnXzd4lv\yCJQVy0JIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBi\nSncjC0PEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODJizszN NHeyUZYyQTVyN{i2NS=>
HepG2 cells NUjnU2pUTnWwY4Tpc44h[XO|YYm= M13VbGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKZYDHNkBk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlIzOyEQvF2= NFXhcFYyQDN7NEmwOy=>
CV1 cells MkO1SpVv[3Srb36gZZN{[Xl? NW[4OYJCSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFVkGgZ4VtdHNiY3:teJJidnOoZXP0[YQhf2m2aDDmeZNm\CCJYXy0MWRDTCCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOzNizszN MlX5NVg5OjZ{MEW=
CV1 cells NVjqPJE5TnWwY4Tpc44h[XO|YYm= NVLreFhJSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFVkGgZ4VtdHNiY3:teJJidnOoZXP0[YQhf2m2aDDmeZNm\CCJYXy0MWRDTCCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9N{41PiEQvF2= NIXIOmQyQDh{NkKwOS=>
U2OS cells NUj5enc1TnWwY4Tpc44h[XO|YYm= MXrB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDpckBWOk:VIHPlcIx{KGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlAzKM7:TR?= MlrPNVg{Ojl5NUG=
Hep G2 cells NV32WmlNTnWwY4Tpc44h[XO|YYm= MlTSRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDoeY1idiCKZYCgS|Ih[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2LVTCSEBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wOEDPxE1? MoHxNVkxPTN5N{[=
HeLa cells MULGeY5kfGmxbjDhd5NigQ>? NUfrd4tRSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFibHnnZY5lKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\UyjIHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiR3HsOE1FSkRiYYPz[ZN{\WRiYYOgeJJidnOlcnnweIlwdmGuIHHjeIl3[XSrb36gZpkhT2GuNDDy[ZNxd26|ZTDlcIVu\W62LXTybZZmdiCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wNVUh|ryP NVjkVIx7OTl{N{W5OlM>
COS1 cells MnmzSpVv[3Srb36gZZN{[Xl? MV3B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TNUBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJIZ2e2WmIInlZZN1KEejbEStSGJFKGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlAzKM7:TR?= NWnGcHAxOTl3M{C2PFE>
U2OS cells NWXqRm45TnWwY4Tpc44h[XO|YYm= NYD5NJBtSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIGWyU3Mh[2WubIOgZpkhdHWlaX\ldoF{\SC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wOUDPxE1? NVS4d3RtOTl3N{SwOVY>
HepG2 cells MkGwSpVv[3Srb36gZZN{[Xl? MojwRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LYTh[4dm\CCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bie3Onc4Pl[EBieyC{ZXPldJRweiC2cnHud4FkfGm4YYTpc44h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFM6KM7:TR?= Mkf4NVk4PzVzNkm=
HepG2 cells NEXUfHVHfW6ldHnvckBie3OjeR?= NXuwe3RsSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOjJ|IN88US=> MXWxPVc5OzR2NB?=
COS7 cells MonPSpVv[3Srb36gZZN{[Xl? MWTB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIILlZ49u[mmwYX70JHBRSVKpYX3tZVIhVEKGIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFT2O3JINmdGy|IHPv[ZhxemW|c3nu[{BISUx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4yKM7:TR?= MWGyNFE{QDd4Mh?=
COS7 cells M{HSTmZ2dmO2aX;uJIF{e2G7 MkPnRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDy[YNwdWKrbnHueEBRWEGUZ3HtcYEyKEyERDDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TO{Bk\WyuczDjc4V5eHKnc4PpcochT0GONDDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODNizszN MXKyNFE{QDd4Mh?=
HEK cells MmHzSpVv[3Srb36gZZN{[Xl? MUjB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFfBUFQufGGpZ3XkJHBRSVKjbIDoZUBkcGmvZYLpZ{Bz\WOncITvdkBmgHC{ZYPz[YQhcW5iSFXLJINmdGy|IHL5JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0yOC53ODFOwG0> MYCyNFI6QTJzNB?=
HEK cells NXP3TXppTnWwY4Tpc44h[XO|YYm= NIi4cohC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJGdCVDRvdHHn[4VlKFCSQWLnZY1u[SClaHnt[ZJq[yC{ZXPldJRweiCneIDy[ZN{\WRiaX6gTGVMKGOnbHzzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCzOUDPxE1? NVXTcIJQOjB{OUmyNVQ>
3T3L1 cells M33nN2Z2dmO2aX;uJIF{e2G7 MVK3JIRigXN? NVXCXVBrUW6mdXP0bY9vKG:oIHHkbZBw\2WwZYPpd{BqdiCvb4Xz[UA{XDOOMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBtcXCrZDDhZ4N2dXWuYYTpc44h[W[2ZYKgO{Bl[Xm|IHL5JG9qdCC{ZXSgU{B{fGGrbnnu[y=> NXrZdIV7OjB3Mke5Olk>
CHO-K1 cells MorkSpVv[3Srb36gZZN{[Xl? MXrQZZJ1cWGuIHHnc45qe3RiYXP0bZZqfHliYYSgbJVu[W5iUGDBVodidW2jLVzCSEBmgHC{ZYPz[YQhcW5iQ1jPMWsyKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT0GONDDhd5Nme3OnZDDhd{BtfWOrZnXyZZNmKGGldHn2bZR6KGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlEh|ryP M{T6fVIxPTJ5OU[5
HEK293T cells MWnGeY5kfGmxbjDhd5NigQ>? M{ThW|Eh|ryP MkfyNlQhcHK| NFn5dYFR[XK2aXHsJIFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hMWxDTCCneIDy[ZN{\WRiaX6gTGVMOjl|VDDj[YxteyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFidV2gZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> Ml\uNlExOzB{NkO=
CV1 cells MUfGeY5kfGmxbjDhd5NigQ>? NUnzXpRnXHKjboPhZ5RqfmG2aX;uJI9nKEejbESt[pV{\WRiaIXtZY4hWFCDUnfhcY1iKESQQTDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlEh|ryP M{C0ZlIyOTF{N{i0
HEK293 cells NXPWOWw1TnWwY4Tpc44h[XO|YYm= M3nx[|E3KHSxIEKwJIhzew>? MkjMWJJidnOjY4TpeoF1cW:wIH;mJGdidDRvZoXz[YQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZYZ1\XJiMU[geI8hOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC0N{DPxE1? MVyyNVEzQDZyMB?=
HepG2 cells M3r3RWZ2dmO2aX;uJIF{e2G7 MUSxNEB2dW:uL1y= Mn3QNlQhcHK| M3rPOGlv[3KnYYPlJIlvKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidX3vcE9NKGGodHXyJFI1KGi{czDy[YxifGm4ZTD0c{Bkd262cn;s M1nQWlIyOjV4N{S4
3T3L1 cell NEH6fJZHfW6ldHnvckBie3OjeR?= NUjQO3l2OSC3TR?= NGTMOGdKdmS3Y4Tpc44hd2ZibX;1d4UhO1R|TEGgZ4VtdCCmaX\m[ZJmdnSrYYTpc44h[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNkfW23bHH0bY9vKG:oIHnueJJi[2WubIXsZZIhdGmyaXSg[JJweGyndDDheEAyKHWPIHL5JG9qdCC{ZXSgU{B{fGGrbnnu[y=> MWiyNVQxOTFzOB?=
CV1 cells MlvZSpVv[3Srb36gZZN{[Xl? M2CwV|QxKGh? M3rFZmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hMWxDTCCneIDy[ZN{\WRiaX6gR3YyKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT2GuNDDh[pRmeiB2MDDodpMh[nlibIXjbYZmemG|ZTDiZZNm\CC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6xJO69VQ>? M3TQeFIyPTF3ME[z
HepG2 cells MWfGeY5kfGmxbjDhd5NigQ>? NXLDVYt5SWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJIh2dWGwIFjldGczKGOnbHzzJIJ6KFCSUlWtcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODFizszN MYGyNVQ5OjR2Nh?=
HepG2 cells NYfFZnA3TnWwY4Tpc44h[XO|YYm= NHv6RmdVemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIGDQVmU{NVSNLVz1Z{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wOUDPxE1? NVuwOmNWOjF2NUC0Olg>
COS7 cells NX35blBCTnWwY4Tpc44h[XO|YYm= M1Lo[m1w\HWuYYTpc44hd2ZiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TO{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGdidDRiYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkh[nlibIXjbYZmemG|ZTDhd5NigSxiRVO1NF0xNjB2MzFOwG0> NYfGd|k5OjF6N{OwO|A>
COS-1 cells MmjFSpVv[3Srb36gZZN{[Xl? MYCyOEBpenN? NGLVTm9C\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGNQWy1zIHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWtZoF{\WRibIXtbY5wdWW2cnnjJIFv[Wy7c3nzMEBGSzVyPUCuNFQ5KM7:TR?= NFHUcGwzOjB3MUC1OC=>
COS1 cells NXv6V5dUTnWwY4Tpc44h[XO|YYm= NVy4R|Z6OjRiaILz MkXhWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIH\1cIwhdGWwZ4ToJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iQ1;TNUBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJHJZWmGucHjhJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yOiEQvF2= NETDSYQzOjF7N{O5Oi=>
MG-63 cells NXzodIRsTnWwY4Tpc44h[XO|YYm= MVrB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hVUdvNkOgZ4VtdHNiYomgdoVxd3K2ZYKg[4Vv\S2kYYPl[EB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMUGg{txO NUPmdpA5OjJ{MkW2OFE>
COS1 cells M1OyVWZ2dmO2aX;uJIF{e2G7 NFi0U2JDcW6maX7nJIFn\mmwaYT5JJRwKGi3bXHuJJdqdGRidInw[UBRWEGUZ3HtcYEhVEKGIHX4dJJme3OnZDDpckBEV1NzIHPlcIx{KGOxLXX4dJJme3OrbnegS2FNPCCkeTDzZ4lvfGmubHH0bY9vKHC{b4jpcYl1gSCjc4PhfS=> MXWyNlA4ODZyNB?=
MG-63 cells M4K4bWZ2dmO2aX;uJIF{e2G7 MlLJNlQhcHK| MW\Nc4R2dGG2aX;uJI9nKG[3bHytcIVv\3SqIHj1cYFvKHCVR{Wt[pV{\WRiUGDBVodidW2jIHX4dJJme3OnZDDpckBOTy14MzDj[YxteyClbz3lfJBz\XO|aX7nJJBIXi2SMj3QVHJGKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFEyKM7:TR?= Ml3aNlI4Ojd2NEi=
Ac2F cells M13hZWZ2dmO2aX;uJIF{e2G7 MW[wMlEhfG9iMUCg{txO MlzGOkBpenN? MlX2RYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5icnH0JGFkOkZiY3XscJMh[XO|ZYPz[YQh[XNibIXjbYZmemG|ZTDhZ5Rqfmm2eTDheEAxNjFidH:gNVAhfU1iYX\0[ZIhPiCqcoOgZpkhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NEf0WZkzOjhzOUG5NC=>
293H DA cells NGWzUpJHfW6ldHnvckBie3OjeR?= NFHIXpQyPiCq MVHB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBNSkRiaX6gbJVu[W5iMkmzTEBFSSClZXzsd{Bi\nSncjCxOkBpenNiYomgWHIuTlKHVDDhZ5RqfmG2aX;uJJJmeG:{dHXyJIF{e2G7LDDFR|UxRTBwMECyOEDPxE1? MlnvNlI2QDJ7N{O=
3T3L1 cells NHfPSVlHfW6ldHnvckBie3OjeR?= M3nRV|ExKHWP MWXJcoNz\WG|ZTDpckBi\Gmyb37lZ5RqdiCvUl7BJIxmfmWuczDpckBVVk[jbIDoZU1qdmS3Y3XkJI1wfXOnIEPUN2wyKGOnbHzzJJBz\XS{ZXH0[YQh[XRiMUCgeW0h[mWob4LlJHRPTi2jbIDoZUBkcGGubHXu[4UhemWuYYTpeoUhfG9iY3;ueJJwdA>? NVjQb2lZOjF6NUGwPFk>
HepG2 cells NXnsfGg3TnWwY4Tpc44h[XO|YYm= MWqxNEB2VQ>? MYSyOEBp MULS[YR2[3Srb36gc4Yh\2y3Y3;z[UBkd26|dX3weIlwdiCrbjDpcpN2dGmwLYLld4l{fGGwdDDoeY1idiCKZYDHNkBk\WyuczDheEAyOCC3TTDh[pRmeiB{NDDodpMh[nliZ3z1Z49{\SCxeHnkZZNmKG2ndHjv[EBqdiCycnXz[Y5k\SCxZjCyNk4zKG2PIH;mJIdtfWOxc3W= NUfRSo1YOjNyMkWyOFQ>
HepG2 cells MYHGeY5kfGmxbjDhd5NigQ>? NGXDcWsyOCC3TR?= NX7pPJJCOjRiaB?= MUfS[YR2[3Srb36gc4Yh\2y3Y3;z[UBkd26|dX3weIlwdiCrbjDpcpN2dGmwLYLld4l{fGGwdDDoeY1idiCKZYDHNkBk\WyuczDheEAyOCC3TTDh[pRmeiB{NDDodpMh[nliZ3z1Z49{\SCxeHnkZZNmKG2ndHjv[EBqdiCycnXz[Y5k\SCxZjCwMlEhfU1ib3[gbY5{fWyrbh?= MXGyN|AzPTJ2NB?=
THP1 cells NF76V3pHfW6ldHnvckBie3OjeR?= MofvNVAxKHWP NYHp[5M{OyCqcoO= M4fGSHRz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhcW5iaIXtZY4hXEiSMTDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBNWFNvaX7keYNm\CCPQ2CxJI1TVkFiZYjwdoV{e2mxbjDheEAyODBidV2gdJJmcW6ldXLheIVlKG[xcjCzJIhzeyCycnnvdkB1dyCOUGOgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEG4JIhzeyCkeTDSWE1RS1JiYX7hcJl{cXNicnXsZZRqfmVidH:geY51emWjdHXkJINwdnS{b3y= NInCW3ozOjl|NEWzOy=>
THP1 cells MVTGeY5kfGmxbjDhd5NigQ>? NX;GN4lXOTByIIXN NV\F[IYzOyCqcoO= NH3YS41VemGwc3HjeIl3[XSrb36gc4YhWFCDUnfhcY1iKGmwIHj1cYFvKFSKUEGgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hVFCVLXnu[JVk\WRiSVy2JI1TVkFiZYjwdoV{e2mxbjDheEAyODBidV2gdJJmcW6ldXLheIVlKG[xcjCzJIhzeyCycnnvdkB1dyCOUGOgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEG4JIhzeyCkeTDSWE1RS1JiYX7hcJl{cXNicnXsZZRqfmVidH:geY51emWjdHXkJINwdnS{b3y= NEX5cJkzOjl|NEWzOy=>
HepG2 cells NEKweXlHfW6ldHnvckBie3OjeR?= MmHjWJJidnOjY4TpeoF1cW:wIH;mJGdCVDRvZoXz[YQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjD0doFve2[nY4Tl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4yKM7:TR?= MXuyNlk{PDV|Nx?=
HepG2 cells MW\GeY5kfGmxbjDhd5NigQ>? MnjQNlAhcA>? NI[5fYxC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJGdCVDRvZoXz[YQhWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMjFOwG0> NF[4RYszOjB6MUmzNi=>
BL21 DE3 cells MYHGeY5kfGmxbjDhd5NigQ>? NV7VNm1KTGm|cHzhZ4Vu\W62IH;mJHs{UF2{b4Pp[4xqfGG8b37lJIZzd21iTj30[ZJucW6jbDDIbZMufGGpZ3XkJIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIFXzZ4hmemmlaHnhJINwdGliQlyyNUBFTTNiY3XscJMh[nlic3PpcpRqdGyjdHnvckBxem:6aX3peJkh[XO|YYmsJGtqRTBwMEe0JO69VQ>? M2TuZlIzODhzOUOy
human L02 cells NVnjepJRTnWwY4Tpc44h[XO|YYm= NYHKeXhESWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFvTFLEJIV5eHKnc4Pl[EBqdiCqdX3hckBNODJiY3XscJMh[29vZYjwdoV{e2mwZzDwS2w{NVOYNECtS2FNPCCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIJie2WmIITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlkh|ryP M1yxelI{OTh4M{C3
HepG2 cells Ml;2SpVv[3Srb36gZZN{[Xl? MV[yNEBp M1P4c3Rz[W6|YXP0bZZifGmxbjDv[kBISUx2LX\1d4VlKGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yM{mg{txO MlLuNlMyPzFyNEW=
HEK293 cells NIrHWI9HfW6ldHnvckBie3OjeR?= NF;GbWoyOCEQvF2= MWTUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJEh2dmuwb4fuJI9zcWerbjmg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJGFROi2SUGLFJIF1KDFyIIXNJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= NXnGfnBTOjN{N{O1NVk>
HEK293 cells MnewSpVv[3Srb36gZZN{[Xl? MkjjRYdwdmm|dDDheEBpfW2jbjDQVGFT\2GvbXGgUGJFKGW6cILld5Nm\CCrbjDoeY1idiCKRVuyPVMh[2WubIOgZ491emGwc3\lZ5Rm\CC5aYToJGdCVDRvTIXjJIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlAxPCEQvF2= NHTrcFIzOzJ6Nke4Oy=>
HEK293 cells MXnGeY5kfGmxbjDhd5NigQ>? NFLOXnczPCCq MXjUdoFve2GldHn2ZZRqd25ib3[gS2FNPCCGQlSt[pV{\WRiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6xJO69VQ>? MYqyN|I6PDh|MB?=
HEK293 cells NYTGU3pvTnWwY4Tpc44h[XO|YYm= NYrLNZJbPDhiaILz MoX5RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDjc5Rz[W6|ZnXjeIVlKHerdHigVHBTTXh2LWTLMYx2[yCjc4Pld5Nm\CCjczDhZ5RqfmG2aX;uJI9nKGy3Y3nm[ZJie2ViYXP0bZZqfHlibXXhd5Vz\WRiYX\0[ZIhPDhiaILzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD12Mz63NUDPxE1? NIfz[XczOzJ4NUi0OC=>
HepG2 cells M3flZWZ2dmO2aX;uJIF{e2G7 MlPnRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LX\1d4VlKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMTFOwG0> NEDJT4EzOzVyMkKxNi=>
HepG2 cells NHe5dpJHfW6ldHnvckBie3OjeR?= NHXVbphC\2:waYP0JIFkfGm4aYT5JIF1KEeDTESt[pV{\WRiUGDBVodidW2jIF20OlNCKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xODJizszN Ml3rNlM2ODJ{MUK=
L6 cells MYPGeY5kfGmxbjDhd5NigQ>? MXqyOEBpenN? NG\STmNKdmS3Y4Tpc44hd2ZiZ3z1Z49{\SC3cIThb4UhcW5icnH0JGw3KGOnbHzzJJB2dHOnZDD3bZRpKENzND3k[Y95gSCpbIXjc5NmKGGodHXyJFI1KGi{czDpckBxemW|ZX7j[UBw\iCrboP1cIlvNCCHQ{WwQVQvPDlizszN MmDpNlM6QTJ6NkK=
L6 cells NH7ucpRHfW6ldHnvckBie3OjeR?= M{fHelE3KGi{cx?= MYTJcoNz\WG|ZTDpckAzNVt|SG2t[IVwgHmpbIXjc5NmKHWydHHr[UBqdiC{YYSgUFYh[2WubIOgZYZ1\XJiMU[gbJJ{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoch[W6jbInzbZMtKEWFNUC9OE45KM7:TR?= NX7UbndROjR6MUO3N|g>
DU145 cells M2XpfmN6fG:2b4jpZ4l1gSCjc4PhfS=> NGHDdok1QCCqcoO= MXjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVE3KM7:TR?= MWWyOFk6PjF2Mx?=
PC3 cells MYrDfZRwfG:6aXPpeJkh[XO|YYm= MlnLOFghcHK| Ml;RR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gVGM{KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEWFNUC9NlAvOyEQvF2= NHT6RpIzPDl7NkG0Ny=>
MDA-MB-231 cells NHXpc3pIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M1vtOFI1KGi{cx?= NF63PVZIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;NT6yN{DPxE1? NF7sZXczPTJ5OEKzOi=>
HEK293 cells Ml\CSpVv[3Srb36gZZN{[Xl? NIfOWIFC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCxJO69VQ>? NWDT[mZjOjV|MEW2PFg>
HepG2 cells NFW3dJFHfW6ldHnvckBie3OjeR?= NXrzVJk4OjBiaILz M{HzU3Rz[W6|YXP0bZZifGmxbjDv[kBRWEGUIITyZY5{\mWldHXkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBRWEGULXz1Z4ln\XKjc3WgZZN{[XluIFXDOVA:OS54IN88US=> NU\BZoJzOjV2M{ezNFQ>
HEK293 cells MULGeY5kfGmxbjDhd5NigQ>? M3juVFI1KGi{cx?= M2nrZ3Rz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> NHLmRpkzPTR2MkOyNi=>
HepG2 cells Mk\pSpVv[3Srb36gZZN{[Xl? M1;oXGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gS2FNPC2SUFHS[4FudWFibHnnZY5lKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOzlizszN MUCyOVQ3OjJ6MR?=
HEK293 cells MUDGeY5kfGmxbjDhd5NigQ>? M3zKUlI1KGi{cx?= NXfZNFEySWexbnnzeEBi[3Srdnn0fUBifCCvb4Xz[UBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bkdy2neIDy[ZN{cW6pIIfpeIghT2GuNDDy[ZBwenSncjD2[YN1d3JiYX\0[ZIhOjRiaILzJIJ6KGS3YXytcJVkcW[ncnHz[UBz\XCxcoTldkBie3OjeTygSWM2OD1yLkCzJO69VQ>? NGn0WXMzPDl3NUi4PS=>
HepG2 cells NHzUXpRHfW6ldHnvckBie3OjeR?= M2LzN|IxKGi{cx?= NWrGXlZpSWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MWRPSSCkaX7kbY5oKGSxbXHpckBnfXOnZDDoeY1idiCSUFHS[4FudWFibHnnZY5lKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCjc4Pld5Nm\CCjczDy[YNmeHSxcjD0doFve2GldHn2ZZRqd25iaX7jeYJifGWmIH\vdkAzOCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMESg{txO Mnz1NlU1QTdzM{K=
HepaR cells MkHaSpVv[3Srb36gZZN{[Xl? NGro[2UyKGSjeR?= M13XemFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincHHSJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEiPR1PTNkBo\W6nIHX4dJJme3Orb36gZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDFiZHH5JIJ6KHG3YX70bZRifGm4ZTDQR3IhdWW2aH;kJJJmdGG2aY\lJJRwKHWwdILlZZRm\CClb370do9t MYCyOVQ6PzF|Mh?=
HepaR cells MmTJSpVv[3Srb36gZZN{[Xl? NH\VW4IyKHWP NH;BeFEyKGSjeR?= NFrZe29C\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDoeY1idiCKZYDhVkBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCDTlfQWGw1KGenbnWg[ZhxemW|c3nvckBifCBzIIXNJIlv[3WkYYTl[EBnd3JiMTDkZZkh[nlicYXhcpRqfGG2aY\lJHBEWiCvZYToc4QhemWuYYTpeoUhfG9idX70doVifGWmIHPvcpRzd2x? Ml2wNlU1QTdzM{K=
HepaR cells NHu2PVJHfW6ldHnvckBie3OjeR?= NWj2e|hYOSC3TR?= MonoNUBl[Xl? MoruRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hTkGEUEGg[4Vv\SCneIDy[ZN{cW:wIHH0JFEhfU1iaX7jeYJifGWmIH\vdkAyKGSjeTDifUByfWGwdHn0ZZRqfmViUFPSJI1mfGixZDDy[YxifGm4ZTD0c{B2dnS{ZXH0[YQh[2:wdILvcC=> MkTSNlU1QTdzM{K=
HEK293 cells NInMVZlHfW6ldHnvckBie3OjeR?= MnLONVAh|ryP MVuyOEBpenN? NH7nS2dVemGwc3HjeIl3[XSrb36gc4YhWFCDUj3nZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[XRiMUCgeW0h[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NUGzSG1{OjR6OUCwPVA>
C2C12 cells MmPkSpVv[3Srb36gZZN{[Xl? NGjvO4s{OCEQvF2= M{\GVVIhcA>? M{jG[Wlv\HWldHnvckBw\iB{LXTlc5h6NVt|SG2t[4x2[2:|ZTD1dJRic2ViaX6gcY92e2ViQ{LDNVIh[2WubIOgZZQhOzBidV2gZYZ1\XJiMjDodpMh[nlibHnxeYllKHOlaX70bYxt[XSrb36gZ492dnSrbnegZY5idHm|aYO= NWfSeI5oOjV6M{W1N|c>
MCF7 cells MX\GeY5kfGmxbjDhd5NigQ>? Mk\xNVYhcA>? NVz5dIo6SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhfHKjboPm[YN1\WRiaX6gbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiBzNjDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFg4KM7:TR?= MX:yOlIzPjR7MB?=
HEK293 cells NH3hVXZHfW6ldHnvckBie3OjeR?= NUPBOI1POTBizszN NFe2OXYzPCCq NG\MempC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[XO|ZYPz[YQh[XNicnXj[ZB1d3JidILhcpNi[3SrdnH0bY9vKGG2IEGwJJVOKGmwY4XiZZRm\CCob4KgNlQhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NIjKVZYzPjN6NEK4Oi=>

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID